RFXAP
Basic information
Region (hg38): 13:36819222-36829104
Links
Phenotypes
GenCC
Source:
- MHC class II deficiency (Supportive), mode of inheritance: AR
- MHC class II deficiency (Strong), mode of inheritance: AR
- MHC class II deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
MHC class II deficiency 4 | AR | Allergy/Immunology/Infectious | Prophylaxis and early and aggressive treatment of infections can be beneficial; BMT has been reported in Bare lymphocyte syndrome, type II | Allergy/Immunology/Infectious; Gastrointestinal | 650344; 7021490; 9118943; 20197681 |
ClinVar
This is a list of variants' phenotypes submitted to
- MHC class II deficiency (6 variants)
- not provided (1 variants)
- MHC CLASS II DEFICIENCY 4 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RFXAP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 36 | 41 | ||||
missense | 74 | 77 | ||||
nonsense | 5 | |||||
start loss | 1 | |||||
frameshift | 8 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 2 | 6 | |||
non coding | 12 | 27 | ||||
Total | 7 | 3 | 97 | 47 | 8 |
Highest pathogenic variant AF is 0.000118
Variants in RFXAP
This is a list of pathogenic ClinVar variants found in the RFXAP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-36819227-C-T | MHC class II deficiency | Uncertain significance (Feb 16, 2018) | ||
13-36819242-C-G | MHC class II deficiency | Uncertain significance (Jan 12, 2018) | ||
13-36819253-C-A | MHC class II deficiency | Uncertain significance (Jan 13, 2018) | ||
13-36819257-T-G | MHC class II deficiency | Uncertain significance (Jan 13, 2018) | ||
13-36819276-G-C | MHC class II deficiency | Uncertain significance (Jan 12, 2018) | ||
13-36819359-T-C | MHC class II deficiency | Uncertain significance (Sep 29, 2019) | ||
13-36819366-G-C | MHC class II deficiency | Likely benign (Mar 18, 2022) | ||
13-36819366-G-T | MHC class II deficiency | Likely benign (Jun 04, 2020) | ||
13-36819371-G-T | MHC class II deficiency • not specified | Uncertain significance (Dec 11, 2023) | ||
13-36819372-T-C | MHC class II deficiency | Conflicting classifications of pathogenicity (Jul 25, 2023) | ||
13-36819377-C-T | MHC class II deficiency | Uncertain significance (Jan 17, 2022) | ||
13-36819381-G-A | MHC class II deficiency • RFXAP-related disorder | Benign/Likely benign (Feb 01, 2024) | ||
13-36819384-C-T | MHC class II deficiency | Likely benign (Dec 17, 2023) | ||
13-36819386-C-T | MHC class II deficiency | Uncertain significance (Apr 28, 2022) | ||
13-36819393-G-T | MHC class II deficiency | Likely benign (Aug 22, 2022) | ||
13-36819395-G-GCA | MHC class II deficiency | Likely pathogenic (Feb 18, 2022) | ||
13-36819401-C-T | MHC class II deficiency • not specified | Uncertain significance (Jun 16, 2024) | ||
13-36819408-C-T | MHC class II deficiency | Uncertain significance (Jun 16, 2020) | ||
13-36819409-G-T | MHC class II deficiency | Uncertain significance (Aug 27, 2021) | ||
13-36819411-G-T | MHC class II deficiency | Likely benign (May 05, 2023) | ||
13-36819412-C-T | MHC class II deficiency | Uncertain significance (May 25, 2022) | ||
13-36819415-C-T | MHC class II deficiency | Uncertain significance (Oct 28, 2022) | ||
13-36819416-A-G | MHC class II deficiency | Uncertain significance (Dec 22, 2018) | ||
13-36819427-C-G | not specified | Uncertain significance (Aug 22, 2023) | ||
13-36819434-C-G | MHC class II deficiency | Conflicting classifications of pathogenicity (Jan 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RFXAP | protein_coding | protein_coding | ENST00000255476 | 3 | 9881 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0233 | 0.919 | 124965 | 0 | 2 | 124967 | 0.00000800 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.04 | 99 | 133 | 0.747 | 0.00000607 | 1730 |
Missense in Polyphen | 41 | 54.681 | 0.7498 | 697 | ||
Synonymous | 0.193 | 52 | 53.8 | 0.967 | 0.00000249 | 542 |
Loss of Function | 1.62 | 4 | 9.36 | 0.427 | 3.97e-7 | 118 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000958 | 0.00000884 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Part of the RFX complex that binds to the X-box of MHC II promoters.;
- Disease
- DISEASE: Bare lymphocyte syndrome 2 (BLS2) [MIM:209920]: A severe combined immunodeficiency disease with early onset. It is characterized by a profound defect in constitutive and interferon- gamma induced MHC II expression, absence of cellular and humoral T-cell response to antigen challenge, hypogammaglobulinemia and impaired antibody production. The consequence include extreme susceptibility to viral, bacterial and fungal infections. {ECO:0000269|PubMed:10072068, ECO:0000269|PubMed:9118943}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Antigen processing and presentation - Homo sapiens (human);Primary immunodeficiency - Homo sapiens (human);Tuberculosis - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.114
Haploinsufficiency Scores
- pHI
- 0.0971
- hipred
- N
- hipred_score
- 0.403
- ghis
- 0.581
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.463
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rfxap
- Phenotype
Gene ontology
- Biological process
- positive regulation of transcription, DNA-templated
- Cellular component
- nucleus;nuclear speck
- Molecular function
- DNA binding;DNA-binding transcription factor activity;transcription coactivator activity